Ligand validation:4WYP

AMP: ADENOSINE MONOPHOSPHATE

AMP is a Ligand Of Interest in 4WYP designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4WYP_AMP_A_401	84%	44%	0.095	0.956	0.89	1.25	1	2	0	0	100%	1
4WYP_AMP_B_401	4%	46%	0.257	0.632	0.85	1.21	1	2	1	0	100%	0.76
8UB2_AMP_A_201	46%	60%	0.118	0.853	0.69	0.83	-	1	0	0	100%	1
8UB0_AMP_A_201	11%	28%	0.172	0.685	0.75	2.09	1	3	1	0	100%	0.4348
6XHE_AMP_A_201	2%	64%	0.351	0.598	0.64	0.75	-	-	1	0	100%	1
3LOQ_AMP_A_271	100%	45%	0.039	0.987	0.82	1.3	-	2	2	0	100%	1
7SNB_AMP_A_303	100%	55%	0.045	0.993	0.75	0.98	-	1	0	0	100%	0.783
4RDH_AMP_C_301	100%	23%	0.039	0.983	1.37	1.79	3	6	0	0	100%	1
3CLT_AMP_C_1262	100%	40%	0.046	0.987	0.91	1.4	1	4	0	0	100%	1
5VEO_AMP_A_524	100%	40%	0.046	0.987	0.86	1.47	-	3	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.